RALEIGH, N.C., December 21, 2020 — Merz Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA)
Coronavirus will ‘thrive in winter’ says doctor They compared the DNA of patients on intensive care wards with healthy people to identify genetic differences that could explain why
Blood cancer: Symptoms explained by healthcare professionals Rebecca Burton, 29, was expecting her third child in June 2019 when doctors told her the shocking news that she had
FRIDAY, Dec. 4, 2020 — African-American men with prostate cancer suffer worse decisional regret than non-African-American men, according to a study published online Nov. 23 in The Journal
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Christmas tree sales are expected
For more than a decade, Hiranmoy Das, Ph.D., has been investigating how Kruppel-like Factor 2 (KLF2), a gene that codes protein into a specific human chromosome, influences the
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Hair loss research is often
Lung cancer patients with a specific genetic alteration lived longer and were protected against metastasis to the brain when treated early with the drug lorlatinib (Lorbrena), according to
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. High blood pressure affects more
Researchers from the University of Seville and the University of Oxford have described how the presence of brain metastases causes acute cerebrovascular dysfunction from the early stages of
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
